Comparison of tramadol and lornoxicam in intravenous regional anesthesia: a randomized controlled trial  by Çelik, Hande et al.
RS
C
r
H
a
b
c
d
R
A
h
0ev Bras Anestesiol. 2016;66(1):44--49
REVISTA
BRASILEIRA  DE
ANESTESIOLOGIA Ofﬁcial  Publication  of  the  Brazilian  Society  of  Anesthesiologywww.sba.com.br
CIENTIFIC ARTICLE
omparison  of  tramadol  and lornoxicam  in intravenous
egional anesthesia:  a randomized  controlled  trial
ande C¸elika, Ruslan Abdullayevb,∗, Erkan Y. Akc¸aboyc, Mustafa Baydarc, Nermin Gög˘üs¸d
Anesthesiology  Department,  Kocaeli  Gölcük  Necati  C¸elik  Hospital,  Kocaeli,  Turkey
Anesthesiology  Department,  Adiyaman  University  Research  Hospital,  Adiyaman,  Turkey
Anesthesiology  Department,  Ankara  Numune  Research  Hospital  ,  Ankara,  Turkey
Anesthesiology  Department,  Hitit  University  Research  Hospital,  C¸orum,  Turkey
eceived  15  June  2014;  accepted  7  July  2014
vailable  online  29  March  2015
KEYWORDS
Intravenous  regional
anesthesia;
IVRA;
Prilocaine;
Tramadol;
Lornoxicam
Abstract
Background  and  objectives:  Tourniquet  pain  is  one  of  the  major  obstacles  for  intravenous
regional anesthesia.  We  aimed  to  compare  tramadol  and  lornoxicam  used  in  intravenous  regional
anesthesia  as  regards  their  effects  on  the  quality  of  anesthesia,  tourniquet  pain  and  postopera-
tive pain  as  well.
Methods:  After  the  ethics  committee  approval  51  patients  of  ASA  physical  status  I--II  aged  18--65
years were  enrolled.  The  patients  were  divided  into  three  groups.  Group  P  (n  =  17)  received
3 mg/kg  0.5%  prilocaine;  group  PT  (n  =  17)  3  mg/kg  0.5%  prilocaine  +  2  mL  (100  mg)  tramadol
and group  PL  (n  =  17)  3  mg/kg  0.5%  prilocaine  +  2  mL  (8  mg)  lornoxicam  for  intravenous  regional
anesthesia.  Sensory  and  motor  block  onset  and  recovery  times  were  noted,  as  well  as  tourniquet
pains and  postoperative  analgesic  consumptions.
Results:  Sensory  block  onset  times  in  the  groups  PT  and  PL  were  shorter,  whereas  the  corre-
sponding recovery  times  were  longer  than  those  in  the  group  P.  Motor  block  onset  times  in  the
groups PT  and  PL  were  shorter  than  that  in  the  group  P,  whereas  recovery  time  in  the  group  PL
was longer  than  those  in  the  groups  P  and  PT.  Tourniquet  pain  onset  time  was  shortest  in  the
group P  and  longest  in  the  group  PL.  There  was  no  difference  regarding  tourniquet  pain  among
the groups.  Group  PL  displayed  the  lowest  analgesic  consumption  postoperatively.
Conclusion:  Adding  tramadol  and  lornoxicam  to  prilocaine  for  intravenous  regional  anesthesia
produces favorable  effects  on  sensory  and  motor  blockade.  Postoperative  analgesic  consumption
can be  decreased  by  adding  tramadol  and  lornoxicam  to  prilocaine  in  intravenous  regional
anesthesia.a  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  All  rights© 2014  Sociedade  Brasileir
reserved.∗ Corresponding author.
E-mail: ruslan jnr@hotmail.com (R. Abdullayev).
ttp://dx.doi.org/10.1016/j.bjane.2014.07.013
104-0014/© 2014 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.
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Comparac¸ão  de  tramadol  e  lornoxicam  em  anestesia  regional  por  via  intravenosa,
um  estudo  randomizado  e  controlado
Resumo
Justiﬁcativa  e  objetivos:  A  dor  relacionada  ao  torniquete  é  um  dos  maiores  obstáculos  para
a anestesia  regional  intravenosa  (ARIV).  Nosso  objetivo  foi  comparar  tramadol  e  lornoxicam
usados em  ARIV  em  relac¸ão  aos  seus  efeitos  sobre  a  qualidade  da  anestesia,  dor  relacionada  ao
torniquete  e  dor  no  pós-operatório.
Métodos:  Após  a  aprovac¸ão  do  Comitê  de  Ética,  51  pacientes  com  estado  físico  ASA  I--II  e  idades
entre 18--65  anos  foram  inscritos.  Os  pacientes  foram  divididos  em  três  grupos.  Grupo  P  (n  =  17)
recebeu  3  mg/kg  de  prilocaína  a  0,5%;  Grupo  PT  (n  =  17)  3  mg/kg  de  prilocaína  a  0,5%  +  2  mL
(100 mg)  de  tramadol  e  Grupo  PL  (n  =  17)  de  3  mg/kg  de  prilocaína  a  0,5%  +  2  mL  (8  mg)  de
lornoxicam  para  ARIV.  O  início  do  bloqueio  sensorial  e  motor  e  os  tempos  de  recuperac¸ão  foram
registrados,  bem  como  a  dor  relacionada  ao  torniquete  e  o  consumo  de  analgésico  no  pós-
operatório.
Resultados:  Os  tempos  de  início  do  bloqueio  sensorial  foram  mais  curtos  nos  grupos  PT  e  PL,
enquanto  que  os  tempos  de  recuperac¸ão  correspondentes  foram  mais  longos  que  os  do  Grupo
P. Os  tempos  de  início  do  bloqueio  motor  nos  grupos  PT  e  PL  foram  menores  que  no  Grupo
P, enquanto  que  o  tempo  de  recuperac¸ão  do  grupo  PL  foi  maior  que  os  dos  grupos  P  e  PT.  O
tempo para  início  da  dor  relacionada  ao  torniquete  foi  menor  no  Grupo  P  e  maior  no  Grupo  PL.
Não houve  diferenc¸a  em  relac¸ão  à  dor  relacionada  ao  torniquete  entre  os  grupos.  O  Grupo  PL
apresentou  o  menor  consumo  de  analgésicos  no  pós-operatório.
Conclusão:  A  adic¸ão  de  tramadol  e  lornoxicam  à  prilocaína  para  ARIV  produz  efeitos  favoráveis
sobre o  bloqueio  sensorial  e  motor.  O  consumo  de  analgésicos  no  pós-operatório  pode  ser
reduzido com  a  adic¸ão  de  tramadol  e  lornoxicam  à  prilocaína  em  ARIV.
© 2014  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os
direitos reservados.
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(Introduction
Intravenous  regional  anesthesia  (IVRA),  commonly  named  a
Bier  Block,  has  been  introduced  in  1908  by  Karl  August  Bier.1
Ease  of  application  of  the  method,  fast  onset  of  anesthe-
sia,  lower  cost  compared  with  general  anesthesia  and  no
need  for  deep  sedation  makes  the  Bier  Block  a  method  of
choice  for  surgical  procedures  on  extremities  lasting  less
than  an  hour.2,3 IVRA  can  be  used  for  emergency  opera-
tions  on  extremities  for  the  patients  with  full  stomach.  It
has  a  success  rate  of  96%--100%  for  upper  extremity  and
is  a  good  alternative  for  peripheral  nerve  block.4,5 Com-
pared  with  general  anesthesia  IVRA  shortens  hospital  length
of  stay,  necessitates  30%  less  nurse  care  and  84%  less  drug
need.6
Because  of  the  high  potential  of  systemic  toxicity  bupiva-
caine  and  etidocaine  are  not  preferred  for  IVRA.  Lidocaine
and  prilocaine  are  the  most  commonly  used  local  anesthet-
ics  for  this.  Prilocaine  metabolism  is  the  fastest  among  all
local  anesthetics.
One  of  the  most  important  factors  preventing  the  use
of  IVRA  is  tourniquet  pain.  Many  adjuvant  drugs  have  been
used  to  decrease  the  tourniquet  pain,  increase  anesthe-
sia  quality  and  decrease  postoperative  pain.  Among  these
are  tramadol,  ketorolac,  lornoxicam,  clonidine,  dexametha-
sone,  paracetamol.7--9We  aimed  in  our  study  to  compare  the  effects  of  tramadol
and  lornoxicam  added  to  prilocaine  for  IVRA  for  patients
undergoing  upper  extremity  surgery.
t
p
pethods
ifty-one  patients  of  ASA  physical  status  I and  II,  aged  18--65
ears  old  undergoing  hand  and  wrist  surgery  (carpal  tun-
el  release,  tendon  repair,  phalanx  fracture  repair,  cystic
ygroma,  dupuytren  contracture  repair)  were  enrolled  in
he  study  after  clinical  trials  ethical  committee  approval
T.C.  Ankara  Valilig˘i I˙l  Sag˘lık  Müdürlüg˘ü,  12.05.2009,  n◦
51920).  The  study  was  conducted  in  the  Ankara  Numune
esearch  Hospital  in  2009.  Written  informed  consent  was
aken  from  all  the  patients.
Patients  were  premedicated  by  midazolam  0.15  mg/kg
nd  atropine  0.01  mg/kg  given  intravenously  from  iv  line
pened  on  the  antecubital  side  of  the  non-operative  arm
 mL/kg/h  isotonic  physiologic  saline  solution  was  started
fterwards.  In  the  operation  room  24  gauge  iv  line  was
laced  on  the  dorsal  part  of  the  arm  that  will  undergo  oper-
tion.  Routine  monitorization  included  non-invasive  blood
ressure  (NIBP),  electrocardiography  (ECG)  and  peripheral
xygen  saturation  (SpO2).  Extremity  that  will  undergo  oper-
tion  was  elevated  for  3  min  before  application  of  Esmarch
andage.  After  the  application  of  bandage  the  proximal  cuff
f  the  double-cuffed  tourniquet  (Tourniquet  2800  ELC,  UMB
edizintecknik,  GmbH,  Germany)  was  inﬂated  100  mmHg
bove  the  systolic  arterial  pressure  of  the  same  extremity
to  at  least  250  mmHg).  Esmarch  bandage  was  removed  after
he  inﬂation  of  the  tourniquet.  Existence  of  the  occlusion
ressure  was  conﬁrmed  by  cessation  of  the  radial  pulse  and
ulse  oximetry  trace.
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Table  1  Demographic  characteristics.
Group  P(n  =  17)  Group  PT(n  =  17)  Group  PL(n =  17)  p
Age  (years)  38.7  ±  15.3  37.8  ±  13.4  38.2  ±  12.6  0.981
Sex (male/female)  8/9  10/7  8/9  0.731
Body weight  (kg)  71.4  ±  7.6  69.5  ±  6.6  74.9  ±  8.8  0.128
Height (cm)  170.9  ±  4.3  171.1  ±  5.1  171.5  ±  6.8  0.940
Body mass  index  (kg/m2)  24.4  ±  2.4  23.8  ±  2.6  25.4  ±  2.4  0.157
ASA (I/II)  9/8  9/8  7/10  0.731
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Patients  were  randomized  into  three  groups  by  the
losed  envelope  system.  Group  P  (n  =  17)  received  3  mg/kg
.5%  prilocaine  (Citanest,  Astrazeneca),  group  PT  (n  =  17)
eceived  3  mg/kg  0.5%  prilocaine  +  2  mL  (100  mg)  tramadol
Contramal,  Abdi I˙brahim)  and  group  PL  (n  =  17)  received
 mg/kg  0.5%  prilocaine  +  2  mL  (8  mg)  lornoxicam  (Xefo,
ycomed)  for  IVRA.
The  drug  solutions  were  applied  by  the  anesthesiologist
rom  the  iv  line  on  the  extremity  that  will  be  operated
hroughout  90  s  period.  After  the  application  of  the  solu-
ion  sensory  blockade  onset  time  was  evaluated  by  pinprick
esting  from  the  median,  radial  and  ulnar  dermatomes  every
0  s.  Sensory  blockade  onset  time  was  noted  as  the  time  from
he  ﬁnishing  of  the  drug  solution  injection  to  the  time  that
ll  dermatomes  of  the  arm  and  forearm  are  negative  for
inprick  testing.  Motor  blockade  onset  time  was  noted  as
he  time  from  the  ﬁnishing  of  the  drug  solution  injection  to
he  time  that  none  of  the  ﬁngers  on  the  hand  can  move.  A
ensory  block  assessment  was  done  by  Visual  Analog  Scale
VAS).  Modiﬁed  Bromage  Scale  was  used  for  motor  block
ssessment  of  the  extremity.  After  the  sensory  block  onset
n  all  the  extremities  the  proximal  tourniquet  was  deﬂated
fter  the  inﬂation  of  the  distal  tourniquet  and  operation  was
tarted.
Tourniquet  pain  was  noted  as  before  tourniquet  inﬂation
BT),  at  the  5th,  10th,  20th  and  30th  minutes  of  tourniquet
T  5,  T  10,  T  20,  T  30)  and  at  the  15th,  30th  and  60th  minutes
fter  the  tourniquet  deﬂation  (AT  15,  AT  30,  AT  60).  Fentanyl
as  used  as  a  rescue  analgesic  during  the  operation  and  the
ose  was  noted.  All  the  side  effects  during  the  anesthesia
nd  surgical  procedure  were  noted.
Tourniquet  time  was  kept  between  30  and  90  min  range
egardless  of  the  duration  of  the  operation.  After  the  deﬂa-
ion  of  the  tourniquet,  time  to  the  positive  pinprick  test  on
edian,  radial  and  ulnar  dermatomes  was  noted  as  sensory
lock  recovery  time  and  time  to  the  start  of  the  movement  of
he  ﬁngers  was  noted  as  motor  block  recovery  time.  Patients
ere  followed-up  for  60  min  in  the  post-anesthesia  care  unit
nd  VAS  scores  for  tourniquet  pain  were  noted  on  15th,  30th
nd  60th  minutes.  Diclofenak  sodium  (Voltaren,  Ciba  Geigy)
w
t
s
Table  2  Sensory  block  onset  and  recovery  times.
Group  P  
Sensory  block  onset  time  (min)  8.0  ±  0.68  
Sensory  block  recovery  time  (min)  4.6  ±  0.70  
a p < 0.05..0  ±  9.8  41.3  ±  9.3  0.940
5  mg  im  was  used  as  a  rescue  analgesic  postoperatively  and
4  h  analgesic  consumption  was  noted.  All  the  side  effects,
f  any,  were  noted.
Statistical  evaluation  was  done  using  SPSS  11.5  soft-
are.  Student’s  t  tests  were  used  for  comparisons  of  data
hich  are  commonly  expected  to  be  normally  distributed,
.g.  demographics,  time  of  the  onset  and  recovery  of
ensory  and  motor  block,  duration  of  the  operation  and
ourniquet,  duration  of  analgesia,  and  intraoperative  and
ostoperative  analgesic  use.  The  Kruskal--Wallis  test  was
sed  for  intraoperative  and  postoperative  VAS.  Signiﬁcance
as  assumed  at  p  ≤  0.05.  Using  pooled  data  from  previous
VRA  lornoxicam/lidocaine  and  tramadol/lidocaine  studies,
e  calculated  that  a  sample  size  of  15  patients  would  permit
 Type  I  error  of  ˛  =  0.05  and  a  power  of  80%.
esults
here  was  no  statistically  signiﬁcant  difference  between  the
roups  regarding  demographic  characteristics  and  operation
imes  (p  >  0.05)  (Table  1).
Sensory  block  onset  times  in  groups  PT  and  PL  were
horter  than  that  in  group  P.  This  difference  was  statistically
igniﬁcant  (p  <  0.001).  Although  the  sensory  block  onset  time
n  group  PL  was  shorter  than  that  in  group  PT,  this  difference
as  not  statistically  signiﬁcant.
Sensory  block  recovery  times  in  groups  PT  and  PL  were
onger  than  that  in  group  P.  This  difference  was  statistically
igniﬁcant  (p  <  0.001).  Sensory  block  recovery  time  in  group
L  was  longer  than  that  in  group  PT  and  this  difference  was
tatistically  signiﬁcant  (p  <  0.001)  (Table  2).
Motor  block  onset  times  in  groups  PT  and  PL  were  shorter
han  that  in  group  P,  this  difference  was  statistically  signif-
cant  (p  <  0.001).  Although  the  motor  block  onset  time  in
roup  PL  was  shorter  than  that  in  group  PT,  this  difference
as  not  statistically  signiﬁcant.
Motor  block  recovery  time  in  group  PL  was  longer  than
hat  in  groups  P  and  PT  and  this  difference  was  statistically
igniﬁcant  (p  <  0.001)  (Table  3).
Group  PT  Group  PL  p
6.0  ±  1.17  5.5  ±  0.77  <0.001a
5.2  ±  0.77  6.9  ±  1.06  <0.001a
Comparison  of  tramadol  and  lornoxicam  in  intravenous  regional  anesthesia  47
Table  3  Motor  block  onset  and  recovery  times.
Group  P  Group  PT  Group  PL  p
Motor  block  onset  time  (min) 11.9  ±  1.11 9.1  ±  0.67  8.8  ±  0.98  <0.001a
Motor  block  recovery  time  (min)  5.1  ±  1.20  4.6  ±  1.34  7.9  ±  1.34  <0.001a
a p < 0.05.
Table  4  Tourniquet  pain  and  fentanyl  consumption.
Group  P  Group  PT  Group  PL  p
Distal  tourniquet  time  (min) 45.3  ±  11.2 45.6  ±  9.5  46.3  ±  9.3  0.963
Patients with  tourniquet  pain 10  (58.8%) 4  (23.5%) 9  (52.9%)  0.086
Tourniquet pain  onset  time  (min)  32.5  ±  4.9  33.7  ±  7.5  39.2  ±  7.3  0.081
Patient number  needing  intraoperative  fentanyl  9  (52.9%)  3  (17.6%)  8  (47.1%)  0.078
Intraoperative  fentanyl  consumption  (g)  66.7  ±  2
BT     T0       T 5     T 10    T 20     T 30      AT 15  AT 30  AT 60
4.5
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There  was  no  statistically  signiﬁcant  difference  among
the  groups  as  regards  the  tourniquet  times.  The  tourni-
quet  pain  onset  time  was  shortest  in  group  P  and  longest
in  group  PL,  but  this  difference  was  not  statistically  signif-
icant  (p  >  0.05).  Rescue  fentanyl  need  was  lowest  in  group
PT,  but  again  this  difference  was  not  statistically  signiﬁcant
(p  >  0.05)  (Table  4).
Patients’  tourniquet  pain  VAS  scores  are  given  in  Fig.  1.
There  was  no  statistically  signiﬁcant  difference  among  the
groups  (p  >  0.05).
Table  5  Postoperative  analgesic  consumption  for  24  h.
Postoperative  diclorone
consumption
Yes  No  p
Group  P  14  (82.4%)  3  0.018a
Group  PT  11  (64.7)%  6
Group  PL 6  (35.3%)  11
a p < 0.05.
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o5  50  ±  0  50  ±  0  0.129
Table  5  illustrates  the  24  h  analgesic  consumption  of
he  patients.  There  was  statistically  signiﬁcant  differ-
nce  among  the  groups  regarding  postoperative  diclorone
onsumption  (p  <  0.05).  Group  PL  displayed  the  lowest  con-
umption  of  diclorone.
None  of  the  patients  experienced  any  side  effects
egarding  local  anesthetic  toxicity.
iscussion
he  main  outcome  of  our  study  was  that  postoperative  anal-
esic  consumption  was  markedly  less  in  the  group  where
ornoxicam  was  added  to  prilocaine.  In  the  groups  with
ramadol  and  lornoxicam  sensory  block  onset  times  were
horter  and  recovery  times  were  longer.  Again,  in  the  groups
ith  tramadol  and  lornoxicam  motor  block  onset  times  were
horter,  whereas  in  the  group  with  lornoxicam  motor  block
ecovery  time  was  markedly  longer.
Tan  et  al.10 have  observed  shorter  onset  of  sensory  and
otor  block  and  less  tourniquet  pain  with  tramadol  50  mg
dded  to  lidocaine  for  IVRA,  even  if  it  was  statistically
nsigniﬁcant.
Acalovschi  et  al.11 have  reported  signiﬁcantly  shorter
nset  time  of  sensory  block  with  tramadol  added  for  IVRA.  In
he  group  with  tramadol  they  have  displayed  longer  recov-
ry  times  for  touch  sensation.  They  attributed  the  inability
f  tramadol  to  make  changes  on  the  motor  block  on  its  low
oncentration.  They  speculated  that  tramadol  used  in  low
oncentrations  affects  small  nerves  and  nerve  endings  and
igher  concentrations  should  be  used  to  affect  nerve  trunks.
hey  used  tramadol  in  0.25%  concentration.  But  Kapral
t  al.12 have  displayed  that  tramadol  in  0.25%  concentration
dded  to  mepivacaine  for  brachial  plexus  blockade  prolongs
he  duration  of  sensory  and  motor  block.  Tramadol  may  have
ifferent  pharmacodynamics  in  IVRA  and  brachial  plexus
lockade.  In  brachial  plexus  blockade  anesthetic  agents  pen-
trate  mixed  nerves  simultaneously,  whereas  in  IVRA  the
rst  effect  place  is  nerve  endings  followed  by  nerve  trunks.13
anglois  et  al.14 have  used  lidocaine  3  mg/kg  with  tramadol
00  mg  for  IVRA  and  observed  no  positive  effect  on  post-
perative  analgesia.  We  observed  in  our  study  that  adding
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18  
ramadol  to  prilocaine  prolongs  tourniquet  pain  onset  time
nd  reduces  fentanyl  need  during  the  operation.
Sen  et  al.15 used  lornoxicam  for  IVRA  and  found  shorter
ensory  and  motor  block  onset  times.  They  have  displayed
ncreased  tourniquet  tolerance,  faster  onset  and  better
uality  of  anesthesia,  less  analgesic  consumption  during  and
fter  the  operation  without  any  side  effects  with  lornoxicam
dded  to  lidocaine  for  IVRA.  Our  ﬁndings  are  compatible  with
hese.  We  also  observed  less  fentanyl  consumption  in  the
roup  with  tramadol,  even  though  the  difference  was  not
tatistically  signiﬁcant.
Kol  et  al.’s9 study  was  the  only  study  investigating
ornoxicam  added  to  prilocaine  for  IVRA  in  the  literature.
his  study  has  demonstrated  longer  sensory  and  motor  block
ecovery  times,  longer  analgesia  and  tourniquet  tolerance
imes  with  lornoxicam  added  for  IVRA.  24  h  analgesic  con-
umption  was  also  less  in  the  group  with  lornoxicam.  Our
ndings  were  coherent  with  these.
As  it  is  known,  local  anesthetic  drugs  have  speciﬁc  pKa
nd  pH  of  IVRA  solution  can  be  increased  to  approximate
hysiological  pH,  thus  showing  more  permeability  through
he  cell  membrane  resulting  in  faster  onset  of  action  of
ocal  anesthetics.15,16 Sen  et  al.15 measured  pH  of  lidocaine
.7,  lornoxicam  8.7  and  lornoxicam--lidocaine  mixture  to  be
.6.  They  have  stated  that  the  faster  onset  of  sensory  and
otor  blockade  may  have  been  attributed  to  the  alkaliniza-
ion  of  the  local  anesthetic  solution  by  adding  lornoxicam.
e  have  not  measured  the  pH  values  of  the  drugs  used  in
ur  study,  but  we  know  that  pH  of  prilocaine  is  6.9  and
f  lornoxicam  is  8.7.  We  think,  similar  to  Sen  et  al.,  that
ddition  of  lornoxicam  may  have  increased  the  pH  value
f  prilocaine  resulting  in  faster  onset  of  sensory  and  motor
lock.
Sen  et  al.15 stated  that  prolonged  motor  block  of  the
xtremity  can  prevent  the  distribution  of  local  anesthetic
nto  the  systemic  circulation,  thus  preventing  local  anes-
hetic  toxicity.  We  have  observed  prolonged  motor  block
n  groups  with  tramadol  and  lornoxicam  compared  with  the
ontrol  group.  No  ﬁndings  of  systemic  toxicity  of  local  anes-
hetics  have  been  observed  in  our  study  and  we  are  in
greement  with  Sen  et  al.’s  opinion.
Reuben  and  Duprat17 have  demonstrated  that  non-
teroidal  anti-inﬂammatory  drugs  (NSAID)  decrease  afferent
ociceptive  signals  and  inﬂammatory  mediators  from  the
urgical  ﬁeld.  The  effect  of  NSAIDs  is  thought  to  be  through
yclooxygenase-2  (COX-2)  enzyme  inhibition,  but  other
echanisms  may  have  been  involved.  NSAIDs  may  inhibit
he  conductance  of  C-ﬁbers  which  are  involved  in  propaga-
ion  of  tourniquet  pain  impulses.18 Besides  this,  some  NSAIDs
xhibit  their  peripheral  antinociceptive  actions  through  K+
hannels.18 Activation  of  NO-cGMP  pathway  may  also  induce
ntinociception  through  K+ channels.18,19 Positive  effects  of
SAIDs  like  lornoxicam  or  ketorolac  on  analgesia  when  used
or  IVRA  are  thought  to  be  through  a  mechanism  other  than
OX-2  inhibition.15,20 Ischemia  and  oxidative  stress  have  also
een  blamed  in  tourniquet  pain.21 Lornoxicam  was  found  to
ave  antioxidative  effects  on  rats,22 thus  its  positive  effects
n  tourniquet  pain  can  be  attributed  to  its  antioxidative
roperties.  Jankovic  et  al.20 have  stated  that  analgesic  prop-
rties  of  NSAIDs  may  be  due  to  their  antioxidant  properties.
anbak  et  al.23 have  compared  ketorolac  and  tenoxicam  for
VRA  and  found  tenoxicam  to  be  better  as  regards  tourniquet
1H.  C¸elik  et  al.
ain.  They  related  this  phenomenon  to  the  antioxidative
roperties  of  tenoxicam.
In  our  study  14  (82.4%)  patients  in  group  P,  11  (64.7%)
atients  in  group  PT  and  only  6  (35.3%)  patients  in  group
L  needed  rescue  analgesics  during  the  ﬁrst  24  h  period
ostoperatively.  Lornoxicam  provided  better  analgesia  post-
peratively  compared  with  tramadol.  Optimal  dose  of
ornoxicam  for  IVRA  is  not  known.  We  used  routine  iv  dose
n  our  study.  Steinberg  et  al.24 have  displayed  that  20  mg
etorolac  used  for  IVRA  is  as  effective  as  60  mg.  Possible
echanisms  for  this  are  high  concentration  of  the  drug  in
he  surgical  ﬁeld,24 binding  of  the  drug  to  the  local  tissue  or
ong  stay  in  the  surgical  ﬁeld.25 Studies  identify  an  optimal
ose  of  lornoxicam  for  IVRA  can  be  performed.
onclusions
n  conclusion,  adding  tramadol  and  lornoxicam  to  prilo-
aine  for  IVRA  produces  favorable  effects  on  sensory  and
otor  blockade.  Postoperative  analgesic  consumption  can
e  decreased  by  adding  tramadol  and  lornoxicam  to  prilo-
aine  in  IVRA.
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